Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1988 Aug;64(4):743–745.

Mannose-mediated targeted immunoadjuvant action of liposomes.

N Garcon 1, G Gregoriadis 1, M Taylor 1, J Summerfield 1
PMCID: PMC1385001  PMID: 3169846

Abstract

The effect of the ligand mannosylated albumin, covalently coupled to the surface of tetanus toxoid-containing dehydration-rehydration vesicles (DRV), on their adjuvanticity was investigated. Toxoid-containing DRV coated with mannosylated albumin bound in vitro to mouse (BALB/c) peritoneal macrophages selectively and to a greater extent than non-mannosylated DRV. ELISA assays of anti-toxoid IgG1 and IgG2b in the sera of BALB/c mice immunized with various toxoid-containing DRV preparations suggest that mannosylated liposomes are superior in immunoadjuvant action to conventional ones. Such targeted adjuvanticity appears to be influenced by the number of ligand molecules available on the surface of liposomes rather than the number of mannose residues on albumin.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. G., Gregoriadis G. Liposomes as immunological adjuvants. Nature. 1974 Nov 15;252(5480):252–252. doi: 10.1038/252252a0. [DOI] [PubMed] [Google Scholar]
  2. Davis D., Davies A., Gregoriadis G. Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response. Immunol Lett. 1987 Apr;14(4):341–348. doi: 10.1016/0165-2478(87)90016-2. [DOI] [PubMed] [Google Scholar]
  3. Davis D., Gregoriadis G. Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics. Immunology. 1987 Jun;61(2):229–234. [PMC free article] [PubMed] [Google Scholar]
  4. Gregoriadis G., Davis D., Davies A. Liposomes as immunological adjuvants: antigen incorporation studies. Vaccine. 1987 Jun;5(2):145–151. doi: 10.1016/0264-410x(87)90063-6. [DOI] [PubMed] [Google Scholar]
  5. Kataoka M., Tavassoli M. Synthetic neoglycoproteins: a class of regents for detection of sugar-recognizing substances. J Histochem Cytochem. 1984 Oct;32(10):1091–1098. doi: 10.1177/32.10.6434628. [DOI] [PubMed] [Google Scholar]
  6. Kinsky S. C. Immunogenicity of liposomal model membranes. Ann N Y Acad Sci. 1978;308:111–123. doi: 10.1111/j.1749-6632.1978.tb22017.x. [DOI] [PubMed] [Google Scholar]
  7. Ofek I., Sharon N. Lectinophagocytosis: a molecular mechanism of recognition between cell surface sugars and lectins in the phagocytosis of bacteria. Infect Immun. 1988 Mar;56(3):539–547. doi: 10.1128/iai.56.3.539-547.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Shek P. N., Sabiston B. H. Immune response mediated by liposome-associated protein antigens. II. Comparison of the effectiveness of vesicle-entrapped and surface-associated antigen in immunopotentiation. Immunology. 1982 Dec;47(4):627–632. [PMC free article] [PubMed] [Google Scholar]
  9. Snyder S. L., Vannier W. E. Immunologic response to protein immobilized on the surface of liposomes via covalent azo-bonding. Biochim Biophys Acta. 1984 May 30;772(3):288–294. doi: 10.1016/0005-2736(84)90145-7. [DOI] [PubMed] [Google Scholar]
  10. Stahl P., Gordon S. Expression of a mannosyl-fucosyl receptor for endocytosis on cultured primary macrophages and their hybrids. J Cell Biol. 1982 Apr;93(1):49–56. doi: 10.1083/jcb.93.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. van Rooijen N., van Nieuwmegen R. Use of liposomes as biodegradable and harmless adjuvants. Methods Enzymol. 1983;93:83–95. doi: 10.1016/s0076-6879(83)93036-7. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES